62370-16-5

Upstream product

• 951155-19-4 2-[2-(1-methyl-2-piperidinyl)ethyl]-benzenamine 4-methylbenzenesulfonate 
• 951238-66-7 1-methyl-2-[(E)-2-(2-nitrophenyl)-ethenyl]-pyridinium 4-methylbenzenesulfonate 
• 109-06-8 α-picoline 
• 552-89-6 2-nitro-benzaldehyde 
• 1360685-63-7 (S)-[2-(o-aminophenethyl)-1-methylpiperidine dibenzoyl-L-tartrate] 
• 77340-84-2 2-(o-nitrostyryl)-pyridine 
• 43027-22-1 1-methyl-2-(2-nitro-trans-styryl)-pyridinium; iodide 
• 62414-73-7 (S)-2-[2-(1-methyl-2-piperidinyl)ethyl]benzenamine (1R,3S)-(+)-camphoric acid salt 

Relevant academic research and scientific papers

Development of a scalable synthesis of a serotonin receptor antagonist

An efficient process was developed for the manufacture of MSA100, a serotonin receptor antagonist, via a five-step synthetic route furnishing a high quality of active pharmaceutical ingredient. Highlights of this synthesis include: (1) replacing carcinoge

ORGANIC COMPOUNDS

The present invention relates to a process for the synthesis of (S)-2'[2-1-(methyl-2-piperidyl) ethyl] cinnamanilide (I) or salts or pharmaceutically acceptable prodrugs thereof.